{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T15:01:24Z","timestamp":1780498884050,"version":"3.54.1"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genome Ed."],"abstract":"<jats:p>CRISPR-Cas9 (clustered regularly interspaced short palindromic repeats-associated protein 9) has emerged as a transformative genome-editing tool with significant therapeutic potential for age-related diseases, including Alzheimer\u2019s disease, Parkinson\u2019s disease, cardiovascular disorders, and osteoporosis. This study presents a bibliometric analysis of CRISPR-Cas9 research in age-related diseases, identifying key contributors, major research hotspots, and critical technological advancements. While promising applications have been demonstrated in gene repair, functional regulation, and molecular interventions, significant barriers persist, including off-target effects, low delivery efficiency, and limited editing in non-dividing cells. Ethical concerns over germline editing and gaps in long-term safety data further complicate clinical translation. Future directions emphasize the development of high-precision Cas9 variants, homology-directed repair-independent tools, and efficient delivery systems, alongside the establishment of international regulatory frameworks and multicenter clinical trials. These efforts are essential to fully realize the potential of CRISPR-Cas9 in addressing the global health challenges of aging.<\/jats:p>","DOI":"10.3389\/fgeed.2025.1558432","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T12:11:28Z","timestamp":1743768688000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Mapping the therapeutic landscape of CRISPR-Cas9 for combating age-related diseases"],"prefix":"10.3389","volume":"7","author":[{"given":"Qiyu","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yida","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"B2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","article-title":"Lysosome-targeting chimaeras for degradation of extracellular proteins","volume":"584","author":"Banik","year":"2020","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2174\/1566523220666201214115024","article-title":"CRISPR\/Cas9 technology as a modern genetic manipulation tool for recapitulating of neurodegenerative disorders in large animal models","volume":"21","author":"Barazesh","year":"2021","journal-title":"Curr. Gene Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3390\/cancers13061400","article-title":"Cancer and aging: two tightly interconnected biological processes","volume":"13","author":"Berben","year":"2021","journal-title":"Cancers"},{"key":"B5","doi-asserted-by":"publisher","first-page":"eabo1815","DOI":"10.1126\/scitranslmed.abo1815","article-title":"Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy","volume":"15","author":"Birch","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00439-018-1933-9","article-title":"Application of CRISPR\/Cas9 technologies combined with iPSCs in the study and treatment of retinal degenerative diseases","volume":"137","author":"Cai","year":"2018","journal-title":"Hum. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.14336\/AD.2019.0927","article-title":"The impact of CRISPR-Cas9 on age-related disorders: from pathology to therapy","volume":"11","author":"Caobi","year":"2020","journal-title":"Aging Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature24268","article-title":"Enhanced proofreading governs CRISPR-Cas9 targeting accuracy","volume":"550","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13059-018-1459-4","article-title":"DeepCRISPR: optimized CRISPR guide RNA design by deep learning","volume":"19","author":"Chuai","year":"2018","journal-title":"Genome Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1080\/15265161.2020.1783024","article-title":"Revising, correcting, and transferring genes","volume":"20","author":"Cwik","year":"2020","journal-title":"Am. J. Bioeth."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1038\/mtna.2016.58","article-title":"CRISPR-Cas9 for in vivo gene therapy: promise and hurdles","volume":"5","author":"Dai","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B13","doi-asserted-by":"publisher","first-page":"030501","DOI":"10.11613\/BM.2019.030501","article-title":"Hallmarks of senescence and aging","volume":"29","author":"Dodig","year":"2019","journal-title":"Biochem. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgrna design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1016\/j.cell.2023.07.039","article-title":"Phage-assisted evolution and protein engineering yield compact, efficient prime editors","volume":"186","author":"Doman","year":"2023","journal-title":"Cell"},{"key":"B16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jbusres.2021.04.070","article-title":"How to conduct a bibliometric analysis: an overview and guidelines","volume":"133","author":"Donthu","year":"2021","journal-title":"J. Bus. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","article-title":"Genome editing. The new frontier of genome engineering with CRISPR-Cas9","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41551-021-00759-0","article-title":"Brain-wide Cas9-mediated cleavage of a gene causing familial Alzheimer's disease alleviates amyloid-related pathologies in mice","volume":"6","author":"Duan","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"B19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u00b7T to G\u00b7C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"118628","DOI":"10.1016\/j.ijpharm.2019.118628","article-title":"Stealth functionalization of biomaterials and nanoparticles by CD47 mimicry","volume":"569","author":"Gheibi Hayat","year":"2019","journal-title":"Int. J. Pharm."},{"key":"B22","doi-asserted-by":"publisher","first-page":"113943","DOI":"10.1016\/j.biopha.2022.113943","article-title":"CRISPR\/Cas9-engineered mesenchymal stromal\/stem cells and their extracellular vesicles: a new approach to overcoming cell therapy limitations","volume":"156","author":"Hazrati","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"14233","DOI":"10.3390\/ijms241814233","article-title":"Evolution of CRISPR\/Cas systems for precise genome editing","volume":"24","author":"Hryhorowicz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature26155","article-title":"Evolved Cas9 variants with broad PAM compatibility and high DNA specificity","volume":"556","author":"Hu","year":"2018","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1126\/science.aad9642","article-title":"Hypoxia as a therapy for mitochondrial disease","volume":"352","author":"Jain","year":"2016","journal-title":"Science"},{"key":"B29","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.3390\/ijms21176240","article-title":"CRISPR-Cas9 DNA base-editing and prime-editing","volume":"21","author":"Kantor","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"7101","DOI":"10.1038\/s41467-021-26714-w","article-title":"Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice","volume":"12","author":"Kenjo","year":"2021","journal-title":"Nat. Commun."},{"key":"B32","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41586-020-03086-7","article-title":"In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice","volume":"589","author":"Koblan","year":"2021","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","first-page":"W171","DOI":"10.1093\/nar\/gkz365","article-title":"CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing","volume":"47","author":"Labun","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e389","DOI":"10.1038\/mtna.2016.92","article-title":"In vivo editing of the human mutant rhodopsin gene by electroporation of plasmid-based CRISPR\/Cas9 in the mouse retina","volume":"5","author":"Latella","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B35","doi-asserted-by":"publisher","first-page":"461","DOI":"10.13345\/j.cjb.170348","article-title":"Functional genetic screening using CRISPR-Cas9 system","volume":"34","author":"Li","year":"2018","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"B36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.stemcr.2014.10.013","article-title":"Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9","volume":"4","author":"Li","year":"2015","journal-title":"Stem Cell Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.biomaterials.2018.04.031","article-title":"Non-viral delivery systems for CRISPR\/Cas9-based genome editing: challenges and opportunities","volume":"171","author":"Li","year":"2018","journal-title":"Biomaterials"},{"key":"B38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12979-023-00395-z","article-title":"The role of NLRP3 inflammasome in aging and age-related diseases","volume":"21","author":"Liang","year":"","journal-title":"Immun. Ageing"},{"key":"B39","doi-asserted-by":"publisher","first-page":"0","DOI":"10.14336\/AD.2024.1495","article-title":"Epigenetic clocks: beyond biological age, using the past to predict the present and future","author":"Liang","year":"","journal-title":"Aging Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e2307595","DOI":"10.1002\/smll.202307595","article-title":"Breaking osteoclast-acid vicious cycle to rescue osteoporosis via an acid responsive organic framework-based neutralizing and gene editing platform","volume":"20","author":"Lin","year":"2024","journal-title":"Small"},{"key":"B41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-022-00293-2","article-title":"Propagation of tau and \u03b1-synuclein in the brain: therapeutic potential of the glymphatic system","volume":"11","author":"Lopes","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"B42","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: an expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","journal-title":"Cell"},{"key":"B43","doi-asserted-by":"publisher","first-page":"803894","DOI":"10.3389\/fnins.2021.803894","article-title":"Application of CRISPR\/Cas9 in Alzheimer's disease","volume":"15","author":"Lu","year":"2021","journal-title":"Front. Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"10168","DOI":"10.1038\/ncomms10168","article-title":"The H-index of a network node and its relation to degree and coreness","volume":"7","author":"L\u00fc","year":"2016","journal-title":"Nat. Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/cvr\/cvae136","article-title":"Advances in nucleic acid-targeted therapies for cardiovascular disease prevention","volume":"120","author":"Makhmudova","year":"2024","journal-title":"Cardiovasc Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/antiox12030651","article-title":"Aging hallmarks and the role of oxidative stress","volume":"12","author":"Maldonado","year":"2023","journal-title":"Antioxidants"},{"key":"B47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"B48","doi-asserted-by":"publisher","first-page":"102114","DOI":"10.1016\/j.arr.2023.102114","article-title":"Exploring Parkinson-associated kinases for CRISPR\/Cas9-based gene editing: beyond alpha-synuclein","volume":"92","author":"Mansour","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"B49","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","article-title":"Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain","volume":"23","author":"Marschallinger","year":"2020","journal-title":"Nat. Neurosci."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e2411032","DOI":"10.1002\/advs.202411032","article-title":"Targeted CRISPR\/Cas9 lipid nanoparticles elicits therapeutic genome editing in head and neck cancer","volume":"12","author":"Masarwy","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B51","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ibra.12179","article-title":"Identification of immune infiltration and PANoptosis-related molecular clusters and predictive model in Alzheimer's disease based on transcriptome analysis","volume":"10","author":"Mei","year":"2024","journal-title":"Ibrain"},{"key":"B52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00005-009-0001-5","article-title":"New developments in the use of citation analysis in research evaluation","volume":"57","author":"Moed","year":"2009","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"B53","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","article-title":"In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer's disease","volume":"22","author":"Park","year":"2019","journal-title":"Nat. Neurosci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"646","DOI":"10.18240\/ijo.2017.04.23","article-title":"Applications of CRISPR\/Cas9 in retinal degenerative diseases","volume":"10","author":"Peng","year":"2017","journal-title":"Int. J. Ophthalmol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/s41586-019-1088-4","article-title":"CD22 blockade restores homeostatic microglial phagocytosis in ageing brains","volume":"568","author":"Pluvinage","year":"2019","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"B57","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"B58","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/crispr.2021.0142","article-title":"Reduction of pre-existing adaptive immune responses against SaCas9 in humans using epitope mapping and identification","volume":"5","author":"Shen","year":"2022","journal-title":"CRISPR J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/978-3-319-09156-3_49","article-title":"Big data clustering: a review","volume":"8583","author":"Shirkhorshidi","year":"2014","journal-title":"Comput. Sci. Its Appl. - ICCSA 2014"},{"key":"B60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/030631277400400102","article-title":"The structure of scientific literatures I: identifying andgraphing specialties","volume":"4","author":"Small","year":"1974","journal-title":"Sci. Stud."},{"key":"B61","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.cell.2011.06.019","article-title":"Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations","volume":"146","author":"Soldner","year":"2011","journal-title":"Cell"},{"key":"B62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature19754","article-title":"Accessory subunits are integral for assembly and function of human mitochondrial complex I","volume":"538","author":"Stroud","year":"2016","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41591-018-0137-0","article-title":"A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells","volume":"24","author":"Vakulskas","year":"2018","journal-title":"Nat. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/cvr\/cvz250","article-title":"CRISPR\/Cas9 gene-editing strategies in cardiovascular cells","volume":"116","author":"Vermersch","year":"2020","journal-title":"Cardiovasc Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e201023222414","DOI":"10.2174\/0115733998263079231011073803","article-title":"Current landscape of various techniques and methods of gene therapy through CRISPR Cas9 along with its pharmacological and interventional therapies in the treatment of type 2 diabetes mellitus","volume":"20","author":"Wal","year":"2024","journal-title":"Curr. Diabetes Rev."},{"key":"B66","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0140-6736(18)33080-0","article-title":"Gene-edited babies: Chinese Academy of medical sciences' response and action","volume":"393","author":"Wang","year":"2019","journal-title":"Lancet"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e3000224","DOI":"10.1371\/journal.pbio.3000224","article-title":"Gene-edited babies: what went wrong and what could go wrong","volume":"17","author":"Wang","year":"2019","journal-title":"PLoS Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.cell.2013.04.025","article-title":"One-step generation of mice carrying mutations in multiple genes by CRISPR\/Cas-mediated genome engineering","volume":"153","author":"Wang","year":"2013","journal-title":"Cell"},{"key":"B69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-022-01518-8","article-title":"Current applications and future perspective of CRISPR\/Cas9 gene editing in cancer","volume":"21","author":"Wang","year":"2022","journal-title":"Mol. Cancer"},{"key":"B70","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12951-024-02554-w","article-title":"Short cell-penetration peptide conjugated bioreducible polymer enhances gene editing of CRISPR system","volume":"22","author":"Wang","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1535682","DOI":"10.3389\/fmed.2025.1535682","article-title":"Recent advances in nanotechnology for Parkinson's disease: diagnosis, treatment, and future perspectives","volume":"12","author":"Yadav","year":"2025","journal-title":"Front. Med. (Lausanne)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"e089607","DOI":"10.1002\/alz.089607","article-title":"Development of a novel swine model carrying humanized APP and PSEN1","volume":"20","author":"Yoon","year":"2024","journal-title":"Alzheimers Dement."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1515\/jdis-2017-0006","article-title":"The methodology function of Cite Space mapping knowledge domains","author":"Yu","year":"2015","journal-title":"Stud. Sci. Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3390\/molecules30040947","article-title":"From origin to the present: establishment, mechanism, evolutions and biomedical applications of the CRISPR\/Cas-based macromolecular system in brief","volume":"30","author":"Yuan","year":"2025","journal-title":"Molecules"},{"key":"B75","doi-asserted-by":"publisher","first-page":"114474","DOI":"10.1016\/j.colsurfb.2024.114474","article-title":"Recent advances in spatiotemporal control of the CRISPR\/Cas9 system","volume":"248","author":"Zhang","year":"2024","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s11427-020-1855-4","article-title":"HDAC inhibitors improve CRISPR-mediated HDR editing efficiency in iPSCs","volume":"64","author":"Zhang","year":"2021","journal-title":"Sci. China Life Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/ibra.12165","article-title":"Systemic mechanism of Panax noteginseng saponins in antiaging based on network pharmacology combined with experimental validation","volume":"10","author":"Zhao","year":"2024","journal-title":"Ibrain"},{"key":"B78","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","article-title":"Plasticity of ether lipids promotes ferroptosis susceptibility and evasion","volume":"585","author":"Zou","year":"","journal-title":"Nature"},{"key":"B79","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","article-title":"Cytochrome p450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis","volume":"16","author":"Zou","year":"","journal-title":"Nat. Chem. Biol."}],"container-title":["Frontiers in Genome Editing"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgeed.2025.1558432\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T12:11:31Z","timestamp":1743768691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgeed.2025.1558432\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,4]]},"references-count":78,"alternative-id":["10.3389\/fgeed.2025.1558432"],"URL":"https:\/\/doi.org\/10.3389\/fgeed.2025.1558432","relation":{},"ISSN":["2673-3439"],"issn-type":[{"value":"2673-3439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,4]]},"article-number":"1558432"}}